Our Mission
The mission of the AMC is to investigate through clinical trials new treatment and prevention interventions and study the pathobiology of malignancies in people living with HIV both in the USA and internationally.
Our Vision
To reduce incidence, morbidity, and mortality of cancers occurring in individuals living with HIV.
AMC Goals
To evaluate new treatments and prevention approaches and establish better standards of care for malignancies in HIV
To contribute to scientific understanding of the pathobiology of cancers in setting of HIV
To conduct research both domestically and in high disease burden areas internationally
To recruit and encourage new investigators to participate in AMC protocols and scientific agenda
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- http://www.amcoperations.com
Aids Malignancy Consortium (Amc) Questions
Aids Malignancy Consortium (Amc)'s website is http://www.amcoperations.com
Aids Malignancy Consortium (Amc)'s LinkedIn profile is https://www.linkedin.com/company/aids-malignancy-consortium-amc
Aids Malignancy Consortium (Amc) has
4 employees.
View email and phone details for 4
employees at Aids Malignancy Consortium (Amc).
Aids Malignancy Consortium (Amc)'s industry is
Public Health
Aids Malignancy Consortium (Amc)'s top competitors are
Advicenne Inc.,
Alcon Research,
Alume Biosciences,
Centro Comprensivo De Cáncer De La Universidad De Puerto Rico / Upr Comprehensive Cancer Center,
Advicenne,
Alliance Foundation Trials, Llc,
Ansun Biopharma, Inc.,
Aim Vaccine Co.,ltd.,
Adlai Nortye,
Amo Pharma Ltd.
Aids Malignancy Consortium (Amc)'s categories are Public Health
Aids Malignancy Consortium (Amc)'s founding year is 2000
